RSV Vaccines (e.g., Arexvy, Abrysvo)

Type: vaccine

Status: FDA Approved

Developer: GSK (Arexvy), Pfizer (Abrysvo)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026